This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.

About UsMissionHistory & MilestonesManagement TeamSupervisory BoardOur Values

Supervisory Board

Udo J Vetter

Chairman of the Board

Udo was appointed chairman of the Supervisory Board in March 2007, succeeding ITM co-founder Dr Maurits Geerlings. As a US-trained pharmacist, Udo has served as Managing Director of various leading pharmaceutical companies throughout his entrepreneurial career and also represents UV-Cap GmbH & Co KG, an investor in ITM. In addition, Udo serves as chairman and member of the supervisory and advisory boards of several innovative companies and institutions and is also a member of the International Leadership Forum of the International Society of Pharmaceutical Engineering (ISPE).

Gunther Strothe

Vice Chairman of the Board

Gunther obtained an MA in Economics and an MBA. Previously, Gunther held several managing functions such as CFO of Hugo Boss AG, Investment Banking at Goldman Sachs, and Managing Director Germany at Oliver Wyman & Company. Moreover, he has been a non-executive member of several boards since 1996. Gunther became a member of ITM´s supervisory board in 2016 and Vice Chairman of the Board in 2020.

Oliver Buck

Oliver is a bio-physicist by education who spent his professional career in a variety of entrepreneurial and management positions in industrial companies. Since January 2005, Oliver has devoted his time and expertise to the progress of ITM as its Chief Executive Officer. His main angle has been the development of ITM's corporate and strategic alignment and its product pipeline. As of April 2012, Oliver actively continues to support ITM in its strategic and global market growth as senior advisor to the CEO.

Oliver holds an advanced degree (Dipl-Phys.) in Theoretical Physics from the Technical University of Munich (TUM) (Germany).

Michael Lee-Chin

Michael joined the supervisory board in May 2019. Michael is founder and chairman of Portland Holdings, a privately held investment company headquartered in Burlington, Ontario, Canada. The company is committed to investing in businesses active in strong, long-term growth industries that also seek to improve the social well-being of the communities in which they operate. The philosophy of Michael Lee-Chin and Portland Holdings is to “do well and do good” – building strong businesses that are giving back to society. For his entrepreneurial and philanthropic work, Michael has received numerous awards and honors.

Manuel Salvisberg

Manuel holds an MA in finance from the University of St. Gallen and the Fudan University in Shanghai. He is a CFA and also a CAIA charterholder. After having worked for The Boston Consulting Group and a private equity firm, Manuel structured and now runs the investments of Dr Uli Sigg, the former Swiss ambassador to China. Manuel sits on numerous boards of directors of technology and financial services companies.

Stefan Sanktjohanser

Stefan studied mechanical engineering and obtained his master's degree at the Technical University of Munich. Subsequently, he earned his MBA at Clark University (Mass./USA), majoring in Corporate Finance and Marketing. He started his professional career at Bain & Company. Today, Stefan is co-founder of Goetzpartners, an independent advisory firm for all key issues of entrepreneurial activities as well as co-founder of the private equity company, DIEP - Deutsche Invest Equity Partners. Stefan joined the Supervisory Board of ITM in April 2020.

Tadd Wessel

Tadd joined the supervisory board in June 2021. He is the Founder and Managing Partner of Petrichor Healthcare Capital Management, a private equity firm focused on the healthcare sector. Tadd was formerly a Managing Director at OrbiMed Advisors and Vice President at Fortress Investment Group. Tadd sits on numerous boards of directors of life sciences companies. He holds an A.B. in Biology from Princeton University.